104182 Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices 

Papadimitriou CA, Dimopoulos M–A, 

Bartsch R [2013]. Trastuzumab 

administration during pregnancy: a 

systematic review and meta-analysis. 

Breast Cancer Res Treat 137(2):349–357, 

https://doi.org/10.1007/s10549-012- 

2368-y. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention, Department of Health and 

Human Services. 

[FR Doc. 2024–30456 Filed 12–19–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Centers for Disease Control and 

Prevention (CDC)/Health Resources 

and Services Administration (HRSA) 

Advisory Committee on HIV, Viral 

Hepatitis and STD Prevention and 

Treatment; Notice of Charter Renewal 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of charter renewal. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), within 

the Department of Health and Human 

Services (HHS), announces the renewal 

of the charter of the Centers for Disease 

Control and Prevention (CDC)/Health 

Resources and Services Administration 

(HRSA) Advisory Committee on HIV, 

Viral Hepatitis and STD Prevention and 

Treatment (CHAC). 

FOR FURTHER INFORMATION CONTACT: 

Jonathan Mermin, M.D., M.P.H., 

Designated Federal Officer, CDC/HRSA 

Advisory Committee on HIV, Viral 

Hepatitis and STD Prevention and 

Treatment, Centers for Disease Control 

and Prevention, Department of Health 

and Human Services, 1600 Clifton Road 

NE, Mailstop H24–6, Atlanta, Georgia 

30329–4027. Telephone: (404) 639– 

8000; email: JMermin@cdc.gov. 

SUPPLEMENTARY INFORMATION: CDC is 

providing notice under 5 U.S.C. 1001– 

1014 of the renewal of the charter of the 

Centers for Disease Control and 

Prevention (CDC)/Health Resources and 

Services Administration (HRSA) 

Advisory Committee on HIV, Viral 

Hepatitis and STD Prevention and 

Treatment, Centers for Disease Control 

and Prevention, Department of Health 

and Human Services. This charter has 

been renewed for a two-year period 

through November 25, 2026. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–30414 Filed 12–19–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Mine Safety and Health Research 

Advisory Committee; Notice of Charter 

Renewal 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of charter renewal. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), within 

the Department of Health and Human 

Services (HHS), announces the renewal 

of the charter of the Mine Safety and 

Health Research Advisory Committee 

(MSHRAC). 

FOR FURTHER INFORMATION CONTACT: 

Robert Randolph, M.S., Designated 

Federal Officer, Mine Safety and Health 

Research Advisory Committee, Centers 

for Disease Control and Prevention, 

Department of Health and Human 

Services, 626 Cochrans Mill Road, 

Pittsburgh, Pennsylvania 15236. 

Telephone: (412) 386–4660; email: 

RRandolph@cdc.gov. 

SUPPLEMENTARY INFORMATION: CDC is 

providing notice under 5 U.S.C. 1001– 

1014 of the renewal of the charter of the 

Mine Safety and Health Research 

Advisory Committee, Centers for 

Disease Control and Prevention, 

Department of Health and Human 

Services. This charter has been renewed 

for a two-year period through November 

30, 2026. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–30408 Filed 12–19–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–R–65 and CMS– 

10142] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by [INSERT DATE 30 

DAYS AFTER DATE OF PUBLICATION 

IN THE FEDERAL REGISTER]. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 


ddrumheller on DSK120RN23PROD with NOTICES1